The League against cancer is campaigning for the possibility of carrying out an antigenic test in situ in order to quickly ensure the absence of infection.
- In France, cancer is the leading cause of death in men and the second in women.
- 1 in 5 men and 1 in 6 women will develop cancer in their lifetime.
While the implementing decrees which confirm the obligation to present the health pass at the entrance to health establishments are official, the League against Cancer is concerned about these access restrictions, for patients and their relatives. .
“Don’t be alone in the face of illness”
“Many questions remain for the concrete reception of sick people in these places of care”, writes the League in a press release. “These questions also concern caregivers, whose presence is decisive for the most fragile sick people who undergo heavy treatment”, add the experts.
“The course of care must allow sick people not to be alone in the face of the disease: for a vulnerable person suffering from cancer, the presence of caregivers during the hospital stay is decisive, unanimously welcomed by all the professionals of health”, activists insist. “This presence must be able to continue so as not to leave the most fragile patients alone during their appointments in health establishments”, they add.
“An in situ antigen test”
The League Against Cancer therefore encourages establishment managers to pay the greatest attention to people and their caregivers when the latter present themselves for scheduled care without being able to present them with a health pass or medical certificate of counter -indication. “A protocolized and coordinated solution must always be offered to them, such as the dispensation of an in situ antigenic test to quickly ensure the absence of infection”, believes the League against cancer.
The League also alerts on priority issues for patients, families and loved ones:
No delay in treatment should be caused: if chemotherapy or radiotherapy care is protocolized to maximize the chances of recovery, many delays in the care of cancer patients have already been observed, in particular during the first covid-19 epidemic peaks. These lead to loss of opportunity that sick people and the League cannot accept.
· No more delays in diagnosis: caused by the sharp drop in screenings over the past 18 months due to the viral pandemic, they pose increased risks for people who discover their cancer late – sometimes too late -.
.
